EVOKE PHARMA, INC. Total Liabilities
EVOKE PHARMA, INC. had Total Liabilities of $12.29 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-11-13
- 2025-09-30: Liabilities $12.29M.
- 2025-06-30: Liabilities $11.69M.
- 2025-03-31: Liabilities $10.53M.
- 2024-12-31: Liabilities $10.48M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2025-09-30 | $12.29M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $11.69M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $10.53M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $10.48M 10-Q · filed 2025-11-13 | |
| 2024-09-30 | $9.77M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $9.47M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $8.96M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $9.65M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $8.73M 10-K/A · filed 2024-05-14 | |
| 2023-06-30 | $8.44M 10-K/A · filed 2024-05-14 | |
| 2023-03-31 | $7.91M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $7.77M 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | $7.88M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $7.21M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $7.09M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $7.02M 10-K · filed 2023-03-21 | |
| 2021-09-30 | $6.88M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $11.59M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $11.48M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $12.65M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $8.67M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $8.64M 10-Q · filed 2020-08-06 | |
| 2019-12-31 | $2.02M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $1.63M 10-K · filed 2019-03-06 | |
| 2018-09-30 | $1.61M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.27M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.20M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $5.78M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $8.70M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $6.39M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $6.90M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $5.51M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $6.11M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $6.16M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $6.12M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $6.07M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $6.37M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $6.30M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $6.19M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $6.04M 10-K · filed 2016-03-10 | $6.11M 10-K · filed 2015-03-04 |
| 2014-09-30 | $1.70M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $1.85M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $4.12M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $3.80M 10-K · filed 2015-03-04 | |
| 2013-09-30 | $4.52M 10-Q · filed 2013-11-13 | |
| 2012-12-31 | $1.55M 10-K · filed 2014-03-25 |